Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae
Mk. Lacy et al., Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae, INT J ANT A, 10(4), 1998, pp. 279-283
The objective of this study was to compare the duration of serum bactericid
al activity (SBA) for clarithromycin, azithromycin, and cefuroxime axetil i
n 12 young healthy volunteers after 5 days of therapy (dosed to steady-stat
e) against two strains each of penicillin (PCN)-susceptible, -intermediate,
and -resistant Streptococcus pneumoniae. This was a randomized, 3-way cros
sover study. All isolates were susceptible to clarithromycin (MICs 0.125 mg
/l) and azithromycin (MICs 0.25-0.5 mg/l), while cefuroxime axetil suscepti
bilities correlated with PCN. Results showed that SEA was maintained for 10
0% of the dosing interval for clarithromycin and 50-100% for azithromycin r
egardless of PCN susceptibility when standard doses were employed. Cefuroxi
me axetil was active only against the PCN-susceptible isolate for 50% of th
e dosing interval, indicating that it should only be used for PCN-susceptib
le S. pneumoniae. (C) 1998 Published by Elsevier Science B.V. and Internati
onal Society of Chemotherapy. All rights reserved.